FORMULATION APPROACHES FOR SUSTAINED RELEASE DOSAGE FORMS: A REVIEW

Authors

  • Sudhir Karna
  • Shashank Chaturvedi
  • Vipin Agrawal
  • Mohammad Alim

Abstract

Over the past 30 years, as the expense and complications involved in marketing new drug entities have increased, with concomitant recognition of
the therapeutic advantages of controlled drug delivery, greater attention has been focused on development of sustained or controlled release drug
delivery systems (DDS). For many disease states, a substantial number of therapeutically effective compounds already exist. The effectiveness of these
drugs is often limited by side effects or necessity to administer the compound in an ethical setting. The goal in designing sustained drug delivery
is to reduce the frequency of dosing or to increase the effectiveness of the drug by localization at the site of action, reducing the dose required or
providing uniform drug delivery. The design of oral sustained release DDS depends on various factors such as, physicochemical properties of drug,
type of delivery system, disease being treated, and patient condition, and treatment duration, presence of food, gastrointestinal motility, and coadministration
of other drugs.
Keywords: Sustained release drug delivery system, Dose frequency, Biological half-life, Physicochemical properties of drugs.

References

. Chein YW. Novel Drug Delivery System. Revised and Expanded.

ed. New York: Marcel Dekker; 2005.

Vamsy KA, Srinath KR, Chowdary PC. Formulation development

nd

b

a

Fig. 6: Schematic illustration of drug release from osmosis sustaining system

and evaluation of divalproex sodium extended release tablet. Int J Res

Pharm Biomed Sci 2011;2:809-32.

Jivraj I I, Martini LG, Thomson CM. An overview of the different

excipients useful for the direct compression of tablets. Pharm Sci

Technolo Today 2000;3(2):58-63.

Vyas SP, Khar RK. Controlled Drug Delivery: Concepts and Advance.

New Delhi: Vallabh Prakashan; 2002. p. 155-95.

.

Longer MA, Robinson JR. Sustained release drug delivery system. In:

Remington JP, editor. The Science and Practice of Pharmacy. 18

ed.

Philadelphia: The Philadelphia College of Pharmacy and Science;

p. 1677-9.

Wani MS, Controlled release system-A. Rev 2008;6(1): www.

pharmainfo.net/review. Available from: http://www.pharmainfo.net/

reviews/controlled-released-system-review.

Bechgaard H, Nielson GH. Controlled release multiple units and single

unit dosage. Drug Dev Ind Pharm 1978;4(1):53-67.

Bhowmik D, Kumar KP, Dutta A, Paswan S. Trends in scope and

opportunities of control release oral drug delivery systems. Crit Rev

Pharm Sci 2012;1:20-33.

Patel H, Panchal DR, Patel U, Brahmbhatt T. Matrix type drug delivery

system: A review. J Pharm Sci Biosci Res 2011;1(3):143-51.

Dixit N, Maurya SD, Bhanu PS. Sustained release drug delivery system.

Indian J Res Pharm Biotechnol 2013;1:305-10.

Kola R, Kumar BP. A detailed description of synthetic and natural

polymers which are used in the formulation of sustained release drug

delivery system: A review. J Chem Pharm Sci 2013;6:161-9.

Ratnaparkhi MP, Gupta JP. Sustained release oral drug delivery system

– An overview. Int J Pharm Res Rev 2013;2:11-21.

Pundir S, Badola A, Sharma D. Sustained release matrix technology

and recent advance in matrix drug delivery system: A review. Int J Drug

Res Tech 2013;3:12-20.

Amabile CM, Bowman BJ. Overview of oral modified-release opioid

products for the management of chronic pain. Ann Pharmacother

;40(7-8):1327-35.

Efentakis M, Peponaki C. Formulation study and evaluation of

matrix and three-layer tablet sustained drug delivery systems based

on Carbopols with isosorbite mononitrate. AAPS PharmSciTech

;9(3):917-23.

Available from: http://www.rxlist.com/k-tab-drug.htm.

Nanjwade BK, Mhase SR, Manvi FV. Formulation of extended release

of metformin HCl matrix tablet. Trop J Pharm Res 2011;10(4):375-83.

Packiaraj JM, Vankateswaran CS, Janakiraman K. Formulation

and evaluation of extended release matrix tablet of clarithromycin

using fluid bed granulation process. Int J Res Pharm Biomed Sci

;4:1318-32.

Gupta BP, Thakur N, Jain NP, Banweer J, Jain S. Osmotically

controlled drug delivery system with associated drugs. J Pharm Pharm

Sci 2010;13(4):571-88.

th

Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 34-41

Karna et al.

Patel RR, Patel JK. Novel technologies of controlled release drug

delivery systems. Syst Rev Pharm 2010;1(2):128-32.

Panikkarakayil H, Nampoothiri M, Kachapilly G, Shameem M,

Raghunath P, Anitha Y. Formulation optimization and evaluation of

aceclofenac sustained release dosages form based on Kollidon sustained

release. Asian J Pharm 2013;7(1):8-14.

Manjunatha KM, Ramana MV, Satyanarayana D. Design and evaluation

of diclofenac sodium controlled drug delivery systems. Indian J Pharm

Sci 2007;69(3):384-9.

Nidhi, Rashid M, Kaur V, Han SS, Sharma S, Mishra N. Microparticles

as controlled drug delivery carrier for the treatment of ulcerative colitis:

A brief review. Saudi Pharm J 2014;Doi: 10.1016/j.jsps.2014.10.001.

Chauhan MJ, Patel SA. A concise review on sustained drug delivery

system and its opportunities. Am J Pharm Tech Res 2012;2:227-38.

Aulton ME. Aulton’s Pharmaceutics - The Design and Manufacture of

Medicine. 3rd ed. New York: Churchill Livingstone; 2007.

Marroum PJ. Bioavailability/Bioequivalence for Oral Controlled

Release Products, Controlled Release Drug Delivery Systems:

Scientific and Regulatory Issues, Fifth International Symposium on

Drug Development, East Brunswick, NJ: May-15-17, 1997.

Kumar KP, Bhowmik D, Srivastava S. Sustained release drug delivery

system potential. Pharm Inov 2012;1:48-60.

Lee TW, Robinson JR. In: Gennaro AR, editor. Remington: The Science

and Practice of Pharmacy. 20th ed. Baltimore: Lippincott Williams and

Wilkins; 2000. p. 903-29.

Scientific and Regulatory Issues. Fifth International Symposium on

Drug Development, East Brunswick, NJ: May 1997. p. 15-7.

Banker GS, Rhodes CT. Sustained and controlled drug delivery system.

Modern Pharmaceutics. 4th ed. New York: Marcel Dekker; 2002.

Shargel L, Pong SW, Yu AB. Modified release drug products. Applied

Biopharmaceutics & Pharmacokinetics. 5th ed. New York: McGrawHill

Medical; 2004.

Bramhamankar DM, Jaiswal SB. Biopharmaceutics and

Pharmacokinetics: Pharmacokinetics. 2

ed. New Delhi: Vallabh

Prakashan; 2009. p. 399-401.

nd

Ratilal DA, Gaikwad PD, Bankar VH, Pawar SP. A review on: Sustained

release technology. Int J Res Ayurveda Pharm 2011;2:1701-8.

B. K. Bansal, Shakya. V, Rewar. S. A New Trend in Oral Sustained

Release Technology; As J Pharm Res Dev 2014;2:91-5.

Robinson JR, Lee VH; Controlled Drug Delivery Fundamentals and

Applications. Revised and expanded. 2

ed. New York: Marcel Dekker;

nd

Khalane L, Alkunte A, Birajdar A. Sustained release drug delivery

system: A concise review. Available from: http://www.pharmatutor.

org/articles/sustained-release-drug-delivery-system-concisereview?page=0,0.

Ankit B, Rathore RP, Tanwar YS, Gupta S, Bhaduka G. Oral sustained

release dosage form: An opportunity to prolong the release of drug. Int

J Adv Res Pharm Biosci 2013;3(1):7-14.

Isha C, Nimrata S, Rana AC, Surbhi G. Oral sustined release drug

delivery system: An overview. Int Res J Pharm Sci 2012;3:1-13.

Published

2015-09-01

How to Cite

Karna, S., S. Chaturvedi, V. Agrawal, and M. Alim. “FORMULATION APPROACHES FOR SUSTAINED RELEASE DOSAGE FORMS: A REVIEW”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 5, Sept. 2015, pp. 34-41, https://innovareacademics.in/journals/index.php/ajpcr/article/view/7185.

Issue

Section

Review Article(s)